Idorsia Pharmaceuticals US Inc.
Wayne, PA
- UEI
- YWKKJS5RYQJ9
- CAGE
- 99J34
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 100 Matsonford Rd Bldg 1 Ste 101, Wayne, PA 19087, USA
- Website
- idorsia.com
- Founded
- 2017
- Employees
- 1K-5K
- Estimated annual revenue
- $250M-$500M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Ascendis Pharma, Inc. | — | 325412 Pharmaceutical Preparation Manufacturing |
| Mylan Pharmaceuticals Inc. | Morgantown, WV | 325412 Pharmaceutical Preparation Manufacturing |
| Astellas Pharma US, Inc. | Northbrook, IL | 325412 Pharmaceutical Preparation Manufacturing |
| Cipla USA Inc. | Warren, NJ | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Avadel CNS Pharmaceuticals, LLC | Chesterfield, MO | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Idorsia Pharmaceuticals US Inc. is a foreign-owned, for-profit corporate entity engaged in the manufacture of goods, including pharmaceuticals and related products. Registered in SAM.gov since February 2022, the company appears focused on supplying specialized medications to government healthcare systems serving veterans and other eligible populations.
Idorsia Pharmaceuticals US Inc. holds an Indefinite Delivery Contract awarded by the Department of Veterans Affairs National Acquisition Center with a potential value of $2,129,424.50 to provide orexin inhibitors over a one-year base period and four option years. The contract aims to establish an indefinite delivery vehicle for a class of sleep-regulating pharmaceuticals, ensuring availability to veteran patients through the VA's Pharmaceutical Prime Vendor Program. Additionally, the company was granted multiple Federal Supply Schedule contracts by VA entities, including a $300,000 award from Veterans Integrated Service Network 12 for drugs, pharmaceuticals, and hematology-related products through September 2027, facilitating the procurement of critical medications for veterans' health services across the region. An interim $25,000 agreement under the same schedule was also awarded to support immediate supply needs.
Quick answers
Is Idorsia Pharmaceuticals US Inc. registered in SAM.gov?
Yes. Idorsia Pharmaceuticals US Inc.'s SAM.gov registration is active through February 11, 2027.
What is Idorsia Pharmaceuticals US Inc.'s CAGE code?
Idorsia Pharmaceuticals US Inc.'s CAGE code is 99J34, and its Unique Entity ID (UEI) is YWKKJS5RYQJ9.
Which contract vehicles does Idorsia Pharmaceuticals US Inc. hold?
Idorsia Pharmaceuticals US Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
On GovTribe
See Idorsia Pharmaceuticals US Inc.'s full federal record
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors